Sofwave Medical Ltd reported financial results for the third quarter and first nine months of fiscal
year 2024, for the period ended September 30, 2024, and recent business highlights
Abstract entitled, “Safety and Efficacy of Synchronous Ultrasound Parallel Beam Technology to Lift the Upper Lip and Improve Perioral Rhytids” selected as the highest rated Cosmetic Dermatologic Su...
Sofwave Medical Ltd announced today that the Company has received 510(k) premarket notification clearance from the FDA to expand the use of Pure ImpactTM in strengthening and improvement in...
Sofwave Medical Ltd announced today that the Company has received 510(k) premarket notification clearance from the FDA to expand the use of Pure ImpactTM in strengthening and improvement in...
Sofwave Medical Ltd, reported financial results for the first quarter and full fiscal 2024 reporting period, for the period ended December 31, 2023, and recent business highlights.
Sofwave Medical Ltd, reported financial results for the first quarter and full fiscal 2024 reporting period, for the period ended December 31, 2023, and recent business highlights.
Sofwave Medical Ltd, reported financial results for the fourth quarter and full fiscal 2023 reporting period, for the period ended December 31, 2023, and recent business highlights.
Sofwave Medical announced the appointment of James Bartholomeusz to the newly created position of Chief Innovation Officer. Mr. Bartholomeusz is a medical aesthetics expert and industry veteran wit...
Sofwave Medical Ltd, announced clearance by the U.S. Food and Drug Administration (FDA) for the Company’s 510(k) premarket notification submission to market Pure Impact™ utilizing PlyoPulse™ EMS (“...
Sofwave Medical Ltd, today announced clearance by the U.S. Food and Drug Administration (FDA) for the Company’s 510(k) premarket notification submission for the improvement of the appearance of ski...
Sofwave Medical Ltd, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the third quarter and first nine months o...
The Sofwave family is appalled by the unconscionable actions that have transpired in Israel in recent days. We stand in solidarity with the victims of these horrific terrorist acts, and we express ...
Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology. The patent protects additional feature sets of SUPERB’s ultrasound and cooling techn...
Sofwave Medical Ltd, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported fourth quarter and full year 2022 financial results for the per...
Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology. The patent protects additional feature sets of SUPERB’s ultrasound and cooling techn...
Sofwave Medical Ltd, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported fourth quarter and full year 2022 financial results for the per...
This year’s award is successive to last year’s recognition as NewBeauty’s winner for “Best in Latest Ultrasound” category
“Precise” delivers the same SUPERB™ technology in a compact applicator head for more convenient and precise treatment of smaller curved areas, such as around the eyes and mouth
Sofwave Medical Ltd, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported fourth quarter and full year 2022 financial results for the per...
Approval granted by Mexico’s Food and Drug Administration, the Federal Commission for the Protection from Sanitary Risks (COFEPRIS), a division of Mexico’s Ministry of Health
Taiwan’s Food and Drug Administration, Division of Medical Devices and Cosmetics, grants Sofwave regulatory approval to market Sofwave featuring SUPERB technology
Sofwave Medical Ltd announced the U.S. Food and Drug Administration’s (FDA) clearance of Sofwave’s SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite...
Sofwave Medical Ltd announces an exclusive collaboration and distribution agreement with DUBIMED Medical Supplies to advance Sofwave sales in the United Arab Emirates. This strategic partnership wi...
SAN CLEMENTE, california, November 8, 2022/PR Newswire/ – Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, r...
SAN CLEMENTE, CALIFORNIA, NOVEMBER 4, 2022/ GLOBENEWSWIRE/ – Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practit...
Sofwave™, the latest game-changing ultrasound technology to revitalize the skin through innovative stimulation of the production of new collagen has been named this year's NewBeauty Award wi...
SAN CLEMENTE, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, repo...
Sofwave Medical Ltd (TASE: SOFW), today announced that it has entered a key collaboration and distribution agreement with HTDK Group to advance Sofwave™ sales in China.
Sofwave™, the aesthetic device company, made its initial public offering on the Tel-Aviv Stock Exchange in May 2021. It reports financial results for the full year 2021 with accelerated grow...
The medical aesthetic company, Sofwave, which completed an IPO on the Tel-Aviv stock exchange in May 2021, provides voluntary data for the first quarter of 2022 with a revenue increase of 40% to $5...
Cosmopolitan, NewBeauty, and SHAPE Name Sofwave™ Technology the Industry's Best
Sofwave™, the latest game-changing ultrasound technology to revitalize the skin through innovative stimulation of the production of new collagen has been named this year's NewBeauty Award winner fo...
Revenueincreasedin2021 to $21.8M vs. $4.3M in 2020
2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020
Record Q4 2021 revenues of $8.9M
Sofwave Medical Ltd has been honored with the Elle Magazine’s “2021 Future of Beauty Awards” and named SofwaveTM as one of the best in the In-Office Skin Treatment Category.
The new indications include Eyebrow lifts and lifting of Lax tissue of the Submental and Neck Areas
80% of patients participating in a multi-site clinical trial saw improvement in just 12 weeks
Sofwave Medical LTD, a medical device aesthetic innovator in the non-invasive skin treatments, today announced the appointment of Assaf Korner as Chief Financial Officer, succeeding Michael Eden ef...
MANHATTAN BEACH, Calif., Sept. 1, 2021 /PRNewswire/ — Dr Glynis Ablon, M.D., F.A.A.D. celebrity Dermatologist and Founder of the Ablon Skin Institute is at the forefront of introducing innovative s...
YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ — Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety (MFDS) to market Sofwave™ its proprieta...
TUSTIN, Calif., June 3, 2021 /PRNewswire/ — On Wednesday, May 26, 2021, Sofwave™ Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE). Sofwave’s™, rapid market adopt...
YOQNEAM, Israel, March 10, 2021 /PRNewswire/ — Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval...
YOQNEAM, Israel, Feb. 24, 2021 /PRNewswire/ — Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance...
